Financials

  • Market Capitalization 26.55 M
  • Employee 40
  • Founded 2015
  • CEO N/A
  • Website www.nextcure.com
  • Headquarter Delaware, United States
  • FIGI BBG00BTH5153
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.72
Price to sales ratio

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4858
IMNN
Imunon, Inc. - Common Stock
2.00 USD+2.04%-1.96%+0.50%-38.46%8.40 M USD
4871
RNAZ
TransCode Therapeutics, Inc. - Common Stock
8.48 USD+1.68%+5.34%+63.71%-10.81%8.06 M USD
4874
ELOX
Eloxx Pharmaceuticals, Inc.
11.35 USD0.00%-5.42%-23.57%+13.50%7.81 M USD
4882
ASBP
Aspire Biopharma Holdings, Inc. - Common Stock
6.00 USD+0.50%+3.27%+19.05%+284.62%7.77 M USD

Frequently asked questions about NextCure, Inc. - Common Stock

What is the NextCure, Inc. - Common Stock stock price today?

The current price of NextCure, Inc. - Common Stock (NXTC) is 7.35. Over the past 24 hours, the stock has changed by +237.16%. Follow the NXTC chart for real-time price dynamics.

What is the stock ticker of NextCure, Inc. - Common Stock?

NextCure, Inc. - Common Stock trades under the ticker NXTC. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is NextCure, Inc. - Common Stock stock going up?

NXTC has changed by +246.70% over the last week, +253.37% over the last month, and -43.89% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was NextCure, Inc. - Common Stock net income for the last quarter?

NextCure, Inc. - Common Stock reported net income of -9.8 M for the last quarter. The previous quarter showed -9.44 M, which means net income changed by -3.82%.

How many employees does NextCure, Inc. - Common Stock have?

As of the latest available data, NextCure, Inc. - Common Stock has 40 employees. Workforce size can provide additional context about the company's scale and operations.

What is NextCure, Inc. - Common Stock EBITDA?

NextCure, Inc. - Common Stock EBITDA is -10.16 M, and its EBITDA margin is -508.1 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy NextCure, Inc. - Common Stock stock?

You can buy NextCure, Inc. - Common Stock (NXTC) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in NextCure, Inc. - Common Stock stock?

Investing in NextCure, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the NXTC chart and related analysis on metatrader.com as part of your research.

News